Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-26-036946
Filing Date
2026-03-31
Accepted
2026-03-31 09:02:23
Documents
75
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0283741-10k_cadrenal.htm   iXBRL 10-K 1445460
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea028374101ex23-1.htm EX-23.1 2205
3 CERTIFICATION ea028374101ex31-1.htm EX-31.1 12623
4 CERTIFICATION ea028374101ex31-2.htm EX-31.2 12537
5 CERTIFICATION ea028374101ex32-1.htm EX-32.1 5365
6 CERTIFICATION ea028374101ex32-2.htm EX-32.2 5100
7 GRAPHIC ea028374101_img1.jpg GRAPHIC 92054
8 GRAPHIC ea028374101_img2.jpg GRAPHIC 31510
9 GRAPHIC ea028374101_img3.jpg GRAPHIC 87034
10 GRAPHIC ea028374101_img4.jpg GRAPHIC 61796
  Complete submission text file 0001213900-26-036946.txt   6455692

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE cvkd-20251231.xsd EX-101.SCH 48936
12 XBRL CALCULATION FILE cvkd-20251231_cal.xml EX-101.CAL 41893
13 XBRL DEFINITION FILE cvkd-20251231_def.xml EX-101.DEF 214947
14 XBRL LABEL FILE cvkd-20251231_lab.xml EX-101.LAB 461127
15 XBRL PRESENTATION FILE cvkd-20251231_pre.xml EX-101.PRE 241734
79 EXTRACTED XBRL INSTANCE DOCUMENT ea0283741-10k_cadrenal_htm.xml XML 484219
Mailing Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 306 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

EIN.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41596 | Film No.: 26817455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)